IMMUNEONCO-B 01541·

Gross margin 100.00%--100.00%0.00%100.00%0.00%100.00%0.00%99.28%0.72% Net margin -14465.15%---74887.36%60422.21%-98305.44%23418.08%-426.96%97878.48%-142.12%284.84% ROE 45.85%---51.70%97.56%-50.71%0.99%-46.52%4.19%-27.62%18.91% ROA -82.09%---47.96%34.13%-43.39%4.58%-34.34%9.05%-19.96%14.37% Revenue growth -----89.38%---28.25%61.13%19109.59%19137.84%108.09%19001.50% Attributable profit growth ----45.03%--5.82%39.21%16.76%10.95%30.80%14.04% Debt-to-assets 279.03%--7.23%271.80%14.44%7.21%26.43%11.99%28.07%1.63% Current ratio 0.28--12.6012.325.926.684.041.883.830.21 Operating cash flow / net profit 0.26--0.590.330.970.380.400.560.920.52 Operating cash flow / revenue -3760.43%---44369.89%40609.46%-95221.24%50851.36%-172.67%95048.57%-131.30%41.38%

Net margin -401.62%---650.95%249.33% Revenue growth -----33.14%-- Attributable profit growth -----7.60%-- Debt-to-assets ----39.50%-- Current ratio ----2.66-- Operating cash flow / net profit 0.86--0.970.11 Operating cash flow / revenue -344.76%---630.11%285.36%

Revenue 5.07M--538.00K89.38%386.00K28.25%74.15M19109.59%154.29M108.09% Other income and gains 10.38M--14.66M41.19%18.25M24.48%11.76M35.53%16.66M41.59% Gross profit 5.07M--538.00K89.38%386.00K28.25%74.15M19109.59%153.18M106.59% Administrative expenses 48.32M--92.80M92.05%80.42M13.33%64.82M19.40%53.94M16.78% Net finance costs 891.00K--787.00K11.67%1.52M93.65%3.45M126.31%5.30M53.78% Income tax ----------------29.00K-- Operating profit -732.06M---402.11M45.07%-377.94M6.01%-313.14M17.14%-213.96M31.67% Profit before tax -732.95M---402.89M45.03%-379.46M5.82%-316.59M16.57%-219.26M30.74% Net profit -732.95M---402.89M45.03%-379.46M5.82%-316.59M16.57%-219.29M30.73% Net profit attributable to owners -732.95M---402.89M45.03%-379.46M5.82%-315.86M16.76%-218.58M30.80%

Revenue 38.03M--25.42M33.14% Other income and gains 9.69M--16.39M69.06% Income tax 0--23.00K-- Profit before tax -152.72M---165.47M8.35% Net profit -152.72M---165.50M8.36% Net profit attributable to owners -152.59M---164.19M7.60%

Cash and cash equivalents ----635.21M--306.98M51.67%477.60M55.58%679.56M42.29% Trade and bills receivables 34.00K--66.00K94.12%39.00K40.91%16.00K58.97%1.00K93.75% Total current assets 704.10M--651.87M7.42%686.70M5.34%867.94M26.39%1.06B21.75% Total assets 892.84M--839.98M5.92%874.59M4.12%922.00M5.42%1.10B19.13% Total current liabilities 2.48B--51.74M97.91%115.91M124.03%214.64M85.18%275.57M28.38% Total liabilities 2.49B--60.76M97.56%126.30M107.88%243.69M92.94%308.27M26.50% Equity attributable to owners -1.60B--779.22M148.75%748.29M3.97%678.90M9.27%791.44M16.58% Total equity -1.60B--779.22M148.75%748.29M3.97%678.30M9.35%790.13M16.49%

Cash and cash equivalents ----647.73M-- Trade and bills receivables ----178.00K-- Total current assets ----991.56M-- Total assets ----1.03B-- Total current liabilities ----372.46M-- Total liabilities ----406.99M-- Equity attributable to owners ----625.94M-- Total equity ----623.33M--

Net cash from operating activities -190.54M---238.71M25.28%-367.55M53.98%-128.03M65.17%-202.58M58.22% Net cash from investing activities -108.72M--49.00K100.05%-294.85M601824.49%37.95M112.87%9.73M74.36% Net cash from financing activities 793.03M--179.38M77.38%331.04M84.54%258.93M21.78%402.36M55.40% Net change in cash 493.77M---59.28M112.01%-331.36M458.97%168.84M150.95%209.51M24.09%

Net cash from operating activities -131.10M---160.20M22.20% Net cash from investing activities 45.20M--16.70M63.05% Net cash from financing activities 16.10M--126.70M686.96%